Tag: Small Pharma - Page 6 - Psychedelic Alpha

Read more about the article Small Pharma Inc. Expands Phase I/IIa Clinical Trial With Additional Study Site

Small Pharma Inc. Expands Phase I/IIa Clinical Trial With Additional Study Site

Post published:June 1, 2021
Post category:Press Release

Read more about the article Small Pharma Provides Update to Patent Portfolio Including Receipt of an in Order for Grant Notice for its Patent Related to Psychedelic Tryptamines

Small Pharma Provides Update to Patent Portfolio Including Receipt of an in Order for Grant Notice for its Patent Related to Psychedelic Tryptamines

Post published:May 7, 2021
Post category:Press Release

Read more about the article Small Pharma Inc. to Commence Trading on the TSX Venture Exchange on May 6, 2021

Small Pharma Inc. to Commence Trading on the TSX Venture Exchange on May 6, 2021

Post published:May 4, 2021
Post category:Press Release

Read more about the article Small Pharma Completes Reverse Take-Over Transaction

Small Pharma Completes Reverse Take-Over Transaction

Post published:April 29, 2021
Post category:Press Release

Read more about the article UK Regulators Approve World’s First DMT for Depression Clinical Trial

UK Regulators Approve World’s First DMT for Depression Clinical Trial

Post published:December 10, 2020
Post category:News

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.